SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-220837
Filing Date
2015-06-12
Accepted
2015-06-11 18:44:25
Documents
15
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d934973d10q.htm 10-Q 471339
2 EX-10.1 d934973dex101.htm EX-10.1 60442
3 EX-10.2 d934973dex102.htm EX-10.2 10348
4 EX-10.3 d934973dex103.htm EX-10.3 10223
5 EX-10.4 d934973dex104.htm EX-10.4 10113
6 EX-10.5 d934973dex105.htm EX-10.5 9353
7 EX-31.1 d934973dex311.htm EX-31.1 5612
8 EX-31.2 d934973dex312.htm EX-31.2 5606
9 EX-32.1 d934973dex321.htm EX-32.1 4258
  Complete submission text file 0001193125-15-220837.txt   3272056

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT vktx-20150331.xml EX-101.INS 331752
11 XBRL TAXONOMY EXTENSION SCHEMA vktx-20150331.xsd EX-101.SCH 33053
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20150331_cal.xml EX-101.CAL 36880
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20150331_def.xml EX-101.DEF 116904
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20150331_lab.xml EX-101.LAB 259895
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20150331_pre.xml EX-101.PRE 189082
Mailing Address 4370 LA JOLLA VILLAGE DRIVE, SUITE 400 LA JOLLA CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE, SUITE 400 LA JOLLA CA 92122 858-546-4385
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 15927093
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences